skip navigation National Eye Institute Site Map Free Publications Contact NEI __________ Search Health Funding News Laboratories Education Jobs About NEI Resources Help Viewing Site Home 
Research is the dominant function.
It is the Division's mission to plan, develop, and conduct human population studies concerned with the cause, prevention, and treatment of eye disease and vision disorders, with emphasis on the major causes of blindness.
This includes studies of incidence and prevalence in defined populations, prospective and retrospective studies of risk factors, natural history studies, clinical trials, genetic studies, and studies to evaluate diagnostic procedures.
The DECR carries out a program of education in biometric and epidemiologic principles and methods for the vision research community.
This program consists of courses, workshops, a fellowship program for ophthalmologists, publications, and consultation and collaboration on research.
The Division provides biometric and epidemiologic assistance to National Eye Institute (NEI) intramural and extramural staff and to vision research workers elsewhere.
The assistance ranges from consultation to collaboration as co-investigators.
Source: Fiscal Year 1994 National Eye Institute Annual Report
Staff
Frederick L. Ferris III, M.D., Director
Senior Staff
Emily Y.
Chew, M.D., Medical Officer Frederick L. Ferris III, M.D., Chief, Clinical Trials Branch George F. Reed, Ph.D., Chief, Biometry Branch Mary Frances Cotch, Ph.D., Chief, Epidemiology Branch Katherine Hall Dabas, RN, COT, Clinical Research Coordinator Rita Hiller, M.S., Medical Statistician Terry A. Cox, MD, Ph.D., Staff Scientist John Paul SanGiovanni, Sc.D., Research Fellow
Administrative Staff
Audrey Georges Iris Kivitz
Recent Publications
Diabetic Retinopathy
Chew EY, Klein ML, Murphy RP, Remaley NA, Ferris FL 3rd; for the Early Treatment Diabetic Retinopathy Study Research Group.
Effects of aspirin on vitreous/preretinal hemorrhage in patients with diabetes mellitus.
Early Treatment Diabetic Retinopathy Study Report No. 20.
Arch Ophthalmol 1995;113:52-55.
The Diabetes Control and Complications Trial Research Group.
The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus.
The Diabetes Control and Complications Trial.
Arch Ophthalmol 1995; 113:36-51.
Gardner TW, Klein R, Moss SE, Ferris FL 3rd, Remaley NA. Digoxin does not accelerate progression of diabetic retinopathy.
Diabetes Care 1995;18:237-240.
Kador PF, Takahashi Y, Wyman M, Ferris FL 3rd.
Diabeteslike proliferative retinal changes in galactose-fed dogs.
Arch Ophthalmol 1995;113:352-354.
The Diabetes Control and Complications Trial Research Group.
Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial.
Ophthalmology 1995;102:657-661.
Chew EY, Mills JL, Metzger BE, Remaley NA, Jovanovic-Peterson L, Knopp RH, Conley M, Rand L, Simpson JL, Holmes LB, Aarons JH, and the National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study.
Metabolic control and progression of retinopathy: The Diabetes in Early Pregnancy Study.
Diabetes Care 1995;18:631-637.
Braun CI, Benson WE, Remaley NA, Chew EY, Ferris, FL 3rd, The Early Treatment Diabetic Retinopathy Study Research Group.
Accommodative amplitudes in the Early Treatment Diabetic Retinopathy Study.
ETDRS Report No. 21.
Retina 1995;15:275-281.
Early Treatment Diabetic Retinopathy Study Research Group.
Focal photocoagulation treatment of diabetic macular edema.
Relation of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS Report no.19.
Arch Ophthalmol 1995;113:1144-1155.
Ferris FL. Summary and Commentary on: Klein R, Klein BE, Moss SE: Relation of glycemic control to diabetic microvascular complications of diabetes mellitus.
Diabetes Spectrum 1996;9:35-36.
Chew EY, Klein ML, Ferris, FL 3rd, Remaley NA, Murphy RP, Chantry K, Hoogwerf BJ, Miller D; for the ETDRS Research Group.
Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy.
Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22.
Arch Ophthalmol 1996;114:1079-1084.
Emanuele N, Klein R, Abraira C, Colwell J, Comstock J, Henderson WG, Levin S, Nuttall F, Sawin C, Silbert C, Lee HS, Johnson-Nagel N, VA CSDM Study Group.
Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM).
Diabetes Care 1996;19:1375-1381.
Diabetes Control and Complications Trial (DCCT) Research Group.
Prospectives in diabetes.
The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
Diabetes 1996;45:1289-1298.
Ferris F. Early photocoagulation in patients with either Type I or Type II diabetes.
Tr Am Ophth Soc 1996;XCIV:505-537.
Ferris FL 3rd, Chew EY, Hoogwerf BJ, Early Treatment Retinopathy Study Research Group.
Serum lipids and diabetic retinopathy.
Diabetes Care 1996;19:1291-1293.
Fong DS, Segal PP, Myers F, Ferris FL, Hubbard LD, Davis MD; for the early Treatment Diabetic Retinopathy Study Research Group.
Subretinal fibrosis in diabetic macular edema ETDRS Report 23.
Arch Ophthalmol 1997;115:873-877.
Chew EY. Diabetic retinopathy and lipid abnormalities.
Current Opinion in Ophthalmology 1997;8:59-62.
Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, Ferris FL 3rd, Knatterud GL; for the Early Treatment Diabetic Retinopathy Study Research Group.
Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report no.18.
Invest Ophthalmol Vis Sci 1998;39:233-252.
The Diabetes Control and Complications Trial Research Group.
Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial.
Arch Ophthalmol 1998;116:874-886.
Fong DS, Ferris FL 3rd, Davis MD, Chew EY; for the Early Treatment Diabetic Retinopathy Study Research Group.
Causes of severe visual loss in the Early Treatment Diabetic Retinopathy Study: ETDRS Report no. 24.
Am J Ophthalmol 1999; 127:137-141.
Chew EY, Benson WE, Remaley NA, Lindley AA, Burton TC, Csaky K, Williams GA, Ferris FL 3rd; for the Early Treatment Diabetic Retinopathy Study Research Group.
Results after lens extraction in patients with diabetic retinopathy.
Early Treatment Diabetic Retinopathy Study Report No.25.
Arch Ophthalmol 1999; 117:1600-1606.
Fong DS, Barton FB, Bresnick GH; for the Early Treatment Diabetic Retinopathy Study Research Group.
Impaired color vision associated with diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report No.15.
Am J Ophthalmol 1999;128:612-617.
Ferris FL 3rd, Davis MD, Aiello LM. Treatment of diabetic retinopathy.
N Engl J Med 1999;341:667-678.
Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, Klein R. Diabetic retinopathy.
Diabetes Care 2000;23(Suppl.):S73-S76.
Cataract
Lopez ML, Freidlin V, Datiles MB 3rd.
Longitudinal study of posterior subcapsular opacities using the National Eye Institute computer planimetry system.
Br J Ophthalmol 1995;79:535-540.
Datiles MB, Magno BV, Freidlin V. Study of nuclear cataract progression using the National Eye Institute Scheimpflug system.
Br J Ophthalmol 1995;79:527-534.
Datiles MB, Lasa MS, Podgor MJ, Hernandez-Galilea E, Magno BV.
Measurement error in assessing the size of cortical cataracts from retroillumination photographs.
Curr Eye Res 1995;13:19-26.
Leske MC, Wu SY, Hyman L, Sperduto R, Underwood B, Chylack LT, Milton RC, Srivastava S, Ansari N, The Lens Opacities Case-Control Study Group.
Biochemical factors in the Lens Opacities Case-Control Study.
Arch Ophthalmol 1995;113:1113-1119.
Lasa MSM, Datiles MB 3rd, Freidlin V. Potential vision tests in patients with cataracts.
Ophthalmology 1995;102:1007-1011.
Podgor MJ, Hiller R, Framingham Eye Studies Group.
Associations of types of lens opacities between and within eyes of individuals: an application of second-order generalized estimating equations.
Stat Med 1996;15:145-156.
Alberti G, Oguni M, Podgor M, Sperduto RD, Tomarev S, Grassi C, Williams S, Kaiser- Kupfer M, Maraini G, and Hejtmancik JF. Glutathione S-transferase M1 genotype and age-related cataracts.
Lack of association in an Italian population.
Invest Ophthalmol Vis Sci 1996;37:1167-1173.
Graziosi P, Rosmini F, Bonacini M, Ferrigno L, Sperduto RD, Milton RC, Maraini G. Location and severity of cortical opacities in different regions of the lens in age-related cataract.
Invest Ophthalmol Vis Sci 1996;37:1698-1703.
Hiller R, Sperduto RD, Podgor MJ, Wilson PWF, Ferris FL 3rd, Colton T, D'Agostino RB, Roseman MJ, Stockman ME, Milton RC. Cigarette smoking and the risk of development of lens opacities.
The Framingham Studies.
Arch Ophthalmol 1997;115:1113-1118.
Braccio L, Camparini M, Graziosi P, Baratta L, Ferrigno, L, Williams SL, Rosmini F, Sperduto RD, Maraini G.
An independent evaluation of the age-related eye disease study (AREDS) cataract grading system.
Curr Eye Res 1998; 17:53-59.
Hiller R, Podgor MJ, Sperduto RD, Nowroozi L, Wilson PWF, D'Agostino RB, Colton T, Framingham Eye Studies Group.
A longitudinal study of body mass index and lens opacities: The Framingham Studies.
Ophthalmology 1998;105:1244-1250.
The Age-Related Eye Disease Study Research Group.
The Age-Related Eye Disease Study (AREDS): Design implications AREDS Report No. 1.
Control Clin Trials 1999;20:573-600.
Worzala K, Hiller R, Sperduto RD, Mutalik K, Murabito JM, Moskowitz M, D'Agostino RB, Wilson PWF. Postmenopausal estrogen use, type of menopause, and lens opacities.
Arch Intern Med 2001;161:1448-1454.
Age-Related Macular Degeneration
Chew EY. Nutritional supplement use and age-related macular degeneration.
Current Opinion in Ophthalmology 1995;6:19-24.
Christen WG, Ajani UA, Glynn RJ, Manson JE, Schaumberg, DA, Chew E, Buring JE, Hennekens CH.
Prospective cohort study of antioxidant vitamin supplement use and the risk of age-related macular degeneration.
Am J Epidemiol 1999;149:476-84.
The Age-Related Eye Disease Study Research Group.
The Age-Related Eye Disease Study (AREDS): Design implications AREDS Report No. 1.
Control Clin Trials 1999;20:573-600.
Statistical Methods
Podgor MJ, Gastwirth JL, Mehta CR. Efficiency robust tests of independence in contingency tables with ordered classifications.
Stat Med 1996;15:2095-2105.
Podgor MJ, Gastwirth JL. Efficiency robust rank tests for stratified data.
In: Brunner E and Denker M (Eds.).
In: Research Developments in Probability and Statistics.
Utrecht, The Netherlands, pp 371-379, 1996.
Podgor MJ, Gastwirth JL. Scores.
In: Armitage P and Colton T (Eds.) Encyclopedia of Biostatistics.
John Wiley 
Freidlin B, Podgor MJ, Gastwirth JL. Efficiency robust tests for survival or ordered categorical data.
Biometrics 1999;55:883-886.
Other
Iwata, F., E.M. Kuehl, G.F. Reed, L.M. McCain, W.A. Gahl, and M.I. Kaiser-Kupfer (1998).
A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal crystals in cystinosis.
Molecular Genetics and Metabolism, 64, 237-242.
Shalev, M., A. Ko, M.P. Gelderman, E. Fortin, G. Reed, S. Slavin, and I. Gery (1999).
Multiformic modulation of endotoxin effects by linomide.
Clinical Immunology, 93, 250-255.
Iwata, F., G.F. Reed, R.C. Caruso, E.M. Kuehl, W.A. Gahl, and M.I. Kaiser-Kupfer (2000).
Correlation of visual acuity and ocular pigmentation with the 16-bp duplication in the HPS-1 gene of Hermansky-Pudlak Syndrome, a form of albinism.
Ophthalmology, 107, 783-789.
Robinson, M.R., G. Reed, K.G. Csaky, M.A. Polis, and S.M. Whitcup (2000).
Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy.
American Journal of Ophthalmology, 130, 49-56.
Buggage, R.R., C.-C. Chan, D.M. Matteson, G.F. Reed, and S.M. Whitcup (2000).
Apoptosis in cytomegalovirus retinitis associated with AIDS.
Current Eye Research, 21, 721-729.
Velez, G., P. Yuan, C. Sung, G. Tansey, G.F. Reed, C.-C. Chan, R.B. Nussenblatt, and M.R. Robinson (2001).
Pharmacokinetics and toxicity of intravitreal chemotherapy for primary intraocular lymphoma.
Archives of Ophthalmology, 119, 1518-1524.
Tsilou, E.T., B.I. Rubin, G.F. Reed, F. Iwata, W. Gahl, and M.I. Kaiser-Kupfer (2002).
Age-related prevalence of anterior segment complications in patients with infantile nephropathic cystinosis.
Cornea, 21, 173-176.
Hiller R, Seigel D, Sperduto RD, Blair N, Burton TC, Farber MD, Gragoudas ES, Gunter EW, Haller J, Seddon JM, Sowell AL, Yanuzzi LA, Eye Disease Case-Control Study Group.
Serum zinc and serum lipid profiles in 778 adults.
Ann Epidemiol 1995;5:490-496.
Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Lee HS, VA CSDM Group.
Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM).
Results of the feasibility trial.
Diabetes Care 1995;18:1113-1123.
Braun CI, Freidlin V, Sperduto RD, Milton RC, Strahlman ER.
The progression of myopia in school age children: data from the Columbia Medical Plan.
Ophthalmic Epidemiology 1996;3:13-21.
The Eye Disease Case-Control Study Group.
Risk factors for central retinal vein occlusion.
Arch Ophthalmol 1996;114:545-554.
The Framingham Offspring Eye Study Group.
Familial aggregation and prevalence of myopia in the Framingham Offspring Eye Study.
Arch Ophthalmol 1996;114:326-332.
Podgor MJ, Remaley NA, Chew E. Associations between siblings for esotropia and exotropia.
Arch Ophthalmol 1996;114:739-744.
Ferris FL, Bailey I. Standardizing the Measurement of Visual Acuity for Clinical Research Studies.
Guidelines from the Eye Care Technology Forum.
Ophthalmology 1996;103:181-182.
Whitcup SM, Csaky KG, Podgor MJ, Chew EY, Perry CH, Nussenblatt RB.
A randomized, masked, cross-over trial of acetazolamide for cystoid macular edema in patients with uveitis.
Ophthalmology 1996;103:1054-1063.
Whitcup SM, Iwata F, Podgor MJ, Valle D, Sran PK, Kaiser-Kupfer MI. Association of thyroid disease with retinitis pigmentosa and gyrate atrophy.
Am J Ophthalmol 1996;122:903-905.
Muccioli C, Belfort R Jr., Podgor M, Sampaio P, de Smet M, Nussenblatt R.
The diagnosis of intraocular inflammation and cytomegalovirus retinitis in HIV-infected patients by laser flare photometry.
Laser flare photometry in HIV-infected patients.
Ocular Immunology and Inflammation 1996;4:75-81.
Martin JL, Laster MJ, Kandel L, Kerschmann RL, Reed GF, Eger EI. Metabolism of compound A by renal cysteine-S-conjugate-lyase is not the mechanism of compound A-induced renal injury in the rat.
Anesth Analg 1996;82:770-774.
Lynn F, Reed GF, Meade BD. Collaborative study for the evaluation of enzyme-linked immunosorbent assays used to measure human antibodies to Bordetella pertussis antigens.
Clin Diagn Lab Immun 1996;3:689-700.
Njoku D, Laster MJ, Gong DH, Eger EI, Reed GF, Martin JL. Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury.
Anesth Analg 1996;84:173-178.
Ferris FL 3rd, Chew EY.
A new era for the treatment of retinoblastoma (Editorial).
Arch Ophthalmol 1996;114:1412.
Ferris FL 3rd, Bailey I. Standardizing the measurement of visual acuity for clinical research studies.
Guidelines from the Eye Care Technology Forum.
Ophthalmology 1996;103:181-182.
The Diabetes Control and Complications Trial Research Group.
Perspectives in diabetes.
The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
Diabetes 1996;45:1289-1298.
Abraira C, Colwell J, Nuttall F, Sawin CT, Henderson W, Comstock JP, Emanuele NV, Levin SR, Pacold I, Lee HS, Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VACSDM) Group.
Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial.
Arch Intern Med 1997;157:181-188.
Shirkey BL, Slavins S, Vistica BP, Podgor MJ, Gery I. Immunomodulatory effects of linomide in animals immunized with immunopathogenic retinal antigens: dissociation between different immune functions.
Clin Exp Immunol 1997;108:539-544.
Iwata F, Patronas NJ, Caruso RC, Podgor MJ, Remaley NA, Kupfer C, Kaiser-Kupfer MI. Association of visual field, cup-disc ratio, and magnetic resonance imaging of optic chiasm.
Arch Ophthalmol 1997;115:729-732.
Martin DF, Ferris FL, Parks DJ, Walton C, Mellow SD, Gibbs D, COMT; Remaley NA, Ashton P, Davis MD, Chan CC, Nussenblatt RB. Ganciclovir implant exchange.
Arch Ophthalmol 1997;115: 1389-1394.
Whitcup SM, Stark-Vancs V, Wittes RE, Solomon D, Podgor MJ, Nussenblatt RB, Chan CC. Association of interleukin 10 in the vitreous and cerebrospinal fluid and primary central nervous system lymphoma.
Arch Ophthalmol 1997;115:1157-1160.
Sperduto RD, Hiller R, Chew E, Seigel D, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Seddon JM, Yannuzzi LA.
Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion.
The Eye Disease Case-Control Study.
Ophthalmology 1998;105:765-771.
Agrawal L, Emanuele NV, Abraira C, Henderson WG, Levin SR, Sawin CT, Silbert CK, Nuttall FZ, Comstock JP, Colwell JA, VA CSDM Group.
Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in Type 2 Diabetes (VA CSDM).
Diabetes Care 1998; 21:510-515.
Abraira C, Henderson WG, Colwell JA, Nuttall FQ, Comstock JP, Emanuele NV, Levin SR, Sawin CT, Silbert CK, VA CSDM Group.
Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes.
VA feasibility study on glycemic control and complications (VA CSDM).
Diabetes Care 1998;21:574-579.
Emanuele N, Azad N, Abraira C, Henderson W, Colwell J, Levin S, Nuttall F, Comstock J, Sawin C, Silbert C, Marcovina S, Lee HS; for the Veterans Affairs Cooperative Study in Diabetes Mellitus Group.
Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins.
Veterans Affairs Cooperative Study in Type II diabetes mellitus.
Arch Intern Med 1998;158:2485-2490.
Caruso RC, Zujewski J, Iwata F, Podgor MJ, Conley BA, Ayres LM, Kaiser-Kupfer MI. Effects of fenretinide (4-HPR) on dark adaptation.
Arch Ophthalmol 1998;116:759-763.
Iwata F, Kuehl EM, Reed GF, McCain LM, Gahl WA, Kaiser-Kupfer MI.
A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis.
Mol Genet Metab 1998;64:237-242.
Chan CC, Vortmeyer AO, Chew EY, Green WR, Matteson DM, Shen DF, Linehan WM, Lubensky IA, Zhuang Z. VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma.
Arch Ophthalmol 1999;117:625-630.
Ferris FL 3rd, Davis MD. Treating 20/20 eyes with diabetic macular edema (Editorial).
Arch Ophthalmol 1999;117:675-676.
Shalev M, Ko A, Gelderman MP, Fortin E, Reed G, Slavin S, Gery I. Multiformic modulation of endotoxin effects by linomide.
Clin Immunol 1999;93:250-255.
Vortmeyer AO, Chan CC, Chew EY, Matteson DM, Shen DF, Wellman A, Weil R, Zhuang Z. Morphologic and genetic analysis of retinal angioma associated with massive gliosis in a patient with von Hippel-Lindau disease.
Graefe's Arch Clin Exp Ophthalmol 1999;237:513-517.
Ferris III FL, Davis MD. Treating 20/20 eye with diabetic macular edema.
Arch Ophthalmol 1999;117: 675-676.
Chew EY, Sperduto RD, Hiller R, Nowroozi L, Seigel D, Yannuzzi LA, Burton TC, Seddon JM, Gragoudas ES, Haller JA, Blair NP, Farber M. Clinical course of macular holes.
The Eye Disease Case-Control Study.
Arch Ophthalmol 1999;117:242-246.
Hiller R, Podgor MJ, Sperduto RD, Wilson PWF, Chew EY, D'Agostino RB. High intraocular pressure and survival: The Framingham Studies.
Am J Ophthalmol 1999;128:440-445.
Whitcup SM, Ferris FL 3rd.
New corticosteroids for the treatment of ocular inflammation (Editorial).
Am J Ophthalmol 1999;127:557-599.
Abraira C, McGuire DK. Intensive insulin therapy in patients with Type 2 diabetes: Implications of the Veterans Affairs (VA CSDM) feasibility trial.
Am Heart J 1999;138:S360-S365.
Beck RW, Ferris FL. Journal editors should not require complete data sets for independent scrutiny.
Arch Ophthalmol 2000;118:275.
Iwata F, Reed GF, Caruso RC, Kuehl EM, Gahl WA, Kaiser-Kupfer MI. Correlation of visual acuity and ocular pigmentation with the 16-bp duplication in the HPS-1 gene of Hermansky-Pudlak syndrome, a form of albinism.
Ophthalmology 2000;107:783-789.
Zhao J, Pan X, Sui R, Munoz SR, Sperduto RD, Ellwein LB. Refractive error study in children: Results from Shunyi District, China.
Am J Ophthalmol 2000;129:427-435.
Maul E, Barroso S, Munoz SR, Sperduto RD, Ellwein LB. Refractive error study in children: Results from La Florida, Chile.
Am J Ophthalmol 2000;129:445-454.
June 2002
[ NEI Home | Site Index | Free Publications | Contact Us ]
[ Health | Funding | News | Laboratories | Education | Jobs | About NEI | Resources | Search ]
[ NEI Privacy Statement | Help Viewing Site | Accessibility | Disclaimer ]
We welcome your questions and comments.
Please send general questions and comments to the NEI Office of Communication, Health Education, and Public Liaison.
Technical questions about this website can be addressed to the NEI Website Manager.
National Eye Institute 31 Center Drive MSC 2510 Bethesda, MD 20892-2510 (301) 496-5248 www.nei.nih.gov H H S logo - link to U. S. Department of Health and Human Services d N I H logo - link to National Institutes of Health d
